Catherine Moukheibir - Apr 5, 2022 Form 3 Insider Report for MoonLake Immunotherapeutics (MLTX)

Role: Director
Signature: /s/ Matthias Bodenstedt, Attorney-in-fact for Catherine Moukheibir
Stock symbol: MLTX
Transactions as of: Apr 5, 2022
Transactions value $: $0
Form type: 3
Date filed: 4/15/2022, 04:06 PM
Previous filing: Mar 17, 2022
Next filing: May 5, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney